Search Within

Marc Ladanyi

Formats
  1. Journal Article (649)
  2. Meeting Abstract (644)
  3. Book Section (13)
  4. Research Letter (8)
  5. Review (7)
  6. Editorial (5)
  7. Guidelines (3)
  8. Conference Paper (1)
  9. Correspondence (1)
  10. Miscellaneous (1)
Groups
  1. Department of Pathology and Laboratory Medicine (1332)
  2. GSK Faculty (1332)
  3. Human Oncology and Pathogenesis Program (1332)
  4. Tow Center for Developmental Oncology (TCDO) (1332)
  5. Department of Medicine (645)
  6. Solid Tumor Oncology Division (616)

More Groups

People
  1. Maria Arcila (300)
  2. Michael Berger (219)
  3. Mark Kris (190)
  4. Gregory Riely (188)
  5. Ahmet Zehir (177)
  6. Natasha Rekhtman (134)

More People

Years
  1. 2025 (19)
  2. 2024 (37)
  3. 2023 (48)
  4. 2022 (72)
  5. 2021 (62)
  6. 2020 (63)

More Years

Publications
  1. Modern Pathology (189)
  2. Laboratory Investigation (155)
  3. Journal of Clinical Oncology (127)
  4. Journal of Molecular Diagnostics (93)
  5. Clinical Cancer Research (86)
  6. Journal of Thoracic Oncology (77)

More Publications

Publishers
  1. Nature Publishing Group (224)
  2. American Association for Cancer Research (201)
  3. Nature Research (191)
  4. American Society of Clinical Oncology (152)
  5. Elsevier Science, Inc. (120)
  6. Elsevier Inc. (97)

More Publishers

Results (1332)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sarcoma classification by DNA methylation profiling
    Journal Article

    Koelsche, C.; Schrimpf, D.; Stichel, D.; Sill, M.; Sahm, F.; Reuss, D. E.; Blattner, M.; Worst, B.; Heilig, C. E.; Beck, K.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • Rapid EGFR mutation detection using the Idylla platform: Single-institution experience of 1200 cases analyzed by an in-house developed pipeline and comparison with concurrent next-generation sequencing results
    Journal Article

    Momeni-Boroujeni, A.; Salazar, P.; Zheng, T.; Mensah, N.; Rijo, I.; Dogan, S.; Yao, J.; Moung, C.; Vanderbilt, C.; Benhamida, J.; more...
    Journal of Molecular Diagnostics (2021)

    Fulltext@MSK | Save
  • A pan-cancer study of somatic TERT promoter mutations and amplification in 30,773 tumors profiled by clinical genomic sequencing
    Journal Article

    Gupta, S.; Vanderbilt, C. M.; Lin, Y. T.; Benhamida, J. K.; Jungbluth, A. A.; Rana, S.; Momeni-Boroujeni, A.; Chang, J. C.; Mcfarlane, T.; Salazar, P.; more...
    Journal of Molecular Diagnostics (2021)

    Fulltext@MSK | Save
  • ROS1 at the crossroads of clinical oncology, molecular diagnostics, and drug development
    Editorial

    Odintsov, I.; Somwar, R.; Ladanyi, M.; Drilon, A.
    JCO Oncology Practice (2021)

    Fulltext@MSK | Save
  • Allele-specific role of ERBB2 in the oncogenic function of EGFR L861Q in EGFR-mutant lung cancers
    Journal Article

    Sato, H.; Offin, M.; Kubota, D.; Yu, H. A.; Wilhelm, C.; Toyooka, S.; Somwar, R.; Kris, M. G.; Ladanyi, M.
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Malignant transformation of a polymorphous low grade neuroepithelial tumor of the young (PLNTY)
    Research Letter

    Bale, T. A.; Sait, S. F.; Benhamida, J.; Ptashkin, R.; Haque, S.; Villafania, L.; Sill, M.; Sadowska, J.; Akhtar, R. B.; Liechty, B.; more...
    Acta Neuropathologica (2021)

    Fulltext@MSK | Save
  • The association between tumor mutational burden and prognosis is dependent on treatment context
    Research Letter

    Valero, C.; Lee, M.; Hoen, D.; Wang, J.; Nadeem, Z.; Patel, N.; Postow, M. A.; Shoushtari, A. N.; Plitas, G.; Balachandran, V. P.; more...
    Nature Genetics (2021)

    Fulltext@MSK | Save
  • Genomic profiling aids classification of diagnostically challenging uterine mesenchymal tumors with myomelanocytic differentiation
    Journal Article

    Selenica, P.; Conlon, N.; Gonzalez, C.; Frosina, D.; Jungbluth, A. A.; Beets-Tan, R. G. H.; Rao, M. K.; Zhang, Y.; Benayed, R.; Ladanyi, M.; more...
    American Journal of Surgical Pathology (2021)

    Fulltext@MSK | Save
  • YES1 amplification as a primary driver of lung tumorigenesis and YES1/YAP1 amplifications as mediators of acquired resistance (AR) to ALK and EGFR tyrosine kinase inhibitors (TKIs)
    Meeting Abstract

    Sato, H.; Kubota, D.; Paik, P. K.; Qiao, H.; Jungbluth, A. A.; Rekhtman, N.; Schoenfeld, A. J.; Yu, H. A.; Riely, G. J.; Lovly, C. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Immuno-transcriptomic profiling identifies actionable genomic alterations in pediatric solid malignancies
    Meeting Abstract

    Wei, J. S.; Brohl, A. S.; Sindiri, S.; Milewski, D.; Song, Y. K.; Nagaraj, S.; Gangalapudi, V.; Wen, X.; Ladanyi, M.; Khan, J.
    Cancer Research (2020)

    Fulltext@MSK | Save